| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $83K | -77.8% |
| SG&A Expense | $1.3M | -2.5% |
| Interest Expense | $4K | +0.0% |
| Net Income | -$2.4M | +43.8% |
| EPS (Basic) | -$0.13 | +45.8% |
| EPS (Diluted) | -$0.13 | +45.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $15K | +143.8% |
| Total Assets | $21K | +40.8% |
| Current Liabilities | $2.3M | +57.7% |
| Total Liabilities | $2.3M | +57.3% |
| Stockholders' Equity | -$2.3M | -57.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$558K | +24.7% |
| Financing Cash Flow | $567K | -24.2% |